IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 294 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $704,622 | +12.9% | 15,534 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $623,902 | +15.4% | 15,206 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $540,818 | +30.3% | 15,132 | +37.8% | 0.00% | – |
| Q4 2022 | $414,903 | -16.2% | 10,985 | -1.9% | 0.00% | -100.0% |
| Q3 2022 | $495,000 | +20.7% | 11,199 | +1.0% | 0.00% | – |
| Q2 2022 | $410,000 | +41.9% | 11,086 | +107.6% | 0.00% | – |
| Q4 2018 | $289,000 | +5.1% | 5,341 | 0.0% | 0.00% | – |
| Q3 2018 | $275,000 | -68.5% | 5,341 | -74.5% | 0.00% | -100.0% |
| Q2 2018 | $873,000 | +228.2% | 20,952 | +246.9% | 0.00% | – |
| Q1 2018 | $266,000 | -51.4% | 6,040 | -44.4% | 0.00% | -100.0% |
| Q4 2017 | $547,000 | -54.6% | 10,872 | -54.3% | 0.00% | -50.0% |
| Q3 2017 | $1,205,000 | -19.5% | 23,772 | -19.2% | 0.00% | 0.0% |
| Q2 2017 | $1,496,000 | +20.7% | 29,412 | -4.5% | 0.00% | 0.0% |
| Q1 2017 | $1,239,000 | -40.1% | 30,811 | -28.7% | 0.00% | -33.3% |
| Q4 2016 | $2,067,000 | +176.0% | 43,207 | +111.4% | 0.00% | +200.0% |
| Q3 2016 | $749,000 | +56.7% | 20,441 | -0.4% | 0.00% | 0.0% |
| Q2 2016 | $478,000 | -28.8% | 20,516 | +23.8% | 0.00% | 0.0% |
| Q1 2016 | $671,000 | -35.4% | 16,568 | -1.2% | 0.00% | 0.0% |
| Q4 2015 | $1,039,000 | – | 16,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |